Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Potential dose-dependant response of a neuroprotective agent Erythropoietin (Epo), in hypoxic-ischemic rats and rat neuronal cultures.

FY 2009-10

Summary
Oxygen is a crucial gas for maintaining body functions appropriately. Hypoxic ischemic encephalopathy (HIE) refers to damage in the brain caused by oxygen deprivation; it can result either in death or in mental retardation, learning disability and epilepsy. Oxygen deprivation related brain damage has no cure. Therefore, research is needed to identify a cure or medications to reduce the damage associated with HIE. In the last decade, hopes were raised about the effect of a hormone named Erythropoietin (Epo) for healing damaged brain. Indeed, we already know that Epo promotes production of red cells in blood, and when the body needs more oxygen different organs can produce Epo. Nowadays, we are able to use laboratory produced Epo in the treatment of anemia caused by different reasons. Studies have shown that synthetic Epo can cross brain barriers and reach the injured area. However, little is known about its mechanism of action. Proposed mechanisms include keeping calcium ions away from damaged areas and reduced death of injured cells. Epo can also block the appearance of harmful molecules in oxygen and energy deprivation. The doses in these research studies vary widely from doses used in clinical practice. Therefore, in this study we aim to show, a-) the effective dose range for Epo b-) if some doses are beneficial but some doses are harmful c-) the mechanism by which Epo produces its protective effects. We will study Epo effects on 7 days old rats and on cell cultures of neurons. We will use magnetic resonance imaging (MRI), microscopic techniques and biochemical assays to evaluate Epo effects. At a minimum, our comprehensive study will advance our understanding of Epo protection in nervous system in the well known oxygen-energy deprived animal model and cell cultures.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
199620
Name
Soylu Hanifi
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Potential dose-dependant response of a neuroprotective agent Erythropoietin (Epo), in hypoxic-ischemic rats and rat neuronal cultures.
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Erythropoietin; Hypoxia; Hypoxic Ischemic Encephalopathy; Neuronal Cell Culture; Neuronal Injury; Neuroprotection; Rat Model
Abstract
Oxygen is a crucial gas for maintaining body functions appropriately. Hypoxic ischemic encephalopathy (HIE) refers to damage in the brain caused by oxygen deprivation; it can result either in death or in mental retardation, learning disability and epilepsy. Oxygen deprivation related brain damage has no cure. Therefore, research is needed to identify a cure or medications to reduce the damage associated with HIE. In the last decade, hopes were raised about the effect of a hormone named Erythropoietin (Epo) for healing damaged brain. Indeed, we already know that Epo promotes production of red cells in blood, and when the body needs more oxygen different organs can produce Epo. Nowadays, we are able to use laboratory produced Epo in the treatment of anemia caused by different reasons. Studies have shown that synthetic Epo can cross brain barriers and reach the injured area. However, little is known about its mechanism of action. Proposed mechanisms include keeping calcium ions away from damaged areas and reduced death of injured cells. Epo can also block the appearance of harmful molecules in oxygen and energy deprivation. The doses in these research studies vary widely from doses used in clinical practice. Therefore, in this study we aim to show, a-) the effective dose range for Epo b-) if some doses are beneficial but some doses are harmful c-) the mechanism by which Epo produces its protective effects. We will study Epo effects on 7 days old rats and on cell cultures of neurons. We will use magnetic resonance imaging (MRI), microscopic techniques and biochemical assays to evaluate Epo effects. At a minimum, our comprehensive study will advance our understanding of Epo protection in nervous system in the well known oxygen-energy deprived animal model and cell cultures.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Soylu, Hanifi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~